首页> 美国卫生研究院文献>International Journal of Nanomedicine >Entrapment of curcumin into monoolein-based liquid crystalline nanoparticle dispersion for enhancement of stability and anticancer activity
【2h】

Entrapment of curcumin into monoolein-based liquid crystalline nanoparticle dispersion for enhancement of stability and anticancer activity

机译:将姜黄素截留在单油精基液晶纳米颗粒分散液中以增强稳定性和抗癌活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite the promising anticancer potential of curcumin, its therapeutic application has been limited, owing to its poor solubility, bioavailability, and chemical fragility. Therefore, various formulation approaches have been attempted to address these problems. In this study, we entrapped curcumin into monoolein (MO)-based liquid crystalline nanoparticles (LCNs) and evaluated the physicochemical properties and anticancer activity of the LCN dispersion. The results revealed that particles in the curcumin-loaded LCN dispersion were discrete and monodispersed, and that the entrapment efficiency was almost 100%. The stability of curcumin in the dispersion was surprisingly enhanced (about 75% of the curcumin survived after 45 days of storage at 40°C), and the in vitro release of curcumin was sustained (10% or less over 15 days). Fluorescence-activated cell sorting (FACS) analysis using a human colon cancer cell line (HCT116) exhibited 99.1% fluorescence gating for 5 μM curcumin-loaded LCN dispersion compared to 1.36% for the same concentration of the drug in dimethyl sulfoxide (DMSO), indicating markedly enhanced cellular uptake. Consistent with the enhanced cellular uptake of curcumin-loaded LCNs, anticancer activity and cell cycle studies demonstrated apoptosis induction when the cells were treated with the LCN dispersion; however, there was neither noticeable cell death nor significant changes in the cell cycle for the same concentration of the drug in DMSO. In conclusion, entrapping curcumin into MO-based LCNs may provide, in the future, a strategy for overcoming the hurdles associated with both the stability and cellular uptake issues of the drug in the treatment of various cancers.
机译:尽管姜黄素具有潜在的抗癌潜力,但由于其溶解性,生物利用度和化学脆弱性差,其治疗应用受到限制。因此,已经尝试了各种配方方法来解决这些问题。在这项研究中,我们将姜黄素截留在基于单油精(MO)的液晶纳米颗粒(LCN)中,并评估了LCN分散体的理化性质和抗癌活性。结果表明,载有姜黄素的LCN分散体中的颗粒是离散且单分散的,包封率几乎为100%。姜黄素在分散体中的稳定性出乎意料地提高了(在40°C储存45天后,约有75%的姜黄素得以存活),并且姜黄素的体外释放得以持续(在15天的时间内达到10%或更少)。使用人类结肠癌细胞系(HCT116)进行的荧光激活细胞分选(FACS)分析显示,加载5μM姜黄素的LCN分散体的荧光门控率为99.1%,而相同浓度的二甲基亚砜(DMSO)中的药物为1.36%,表明细胞摄取明显增强。与姜黄素负载的LCN的细胞摄取增加一致,抗癌活性和细胞周期研究表明,当用LCN分散液处理细胞时,可以诱导细胞凋亡。但是,对于相同浓度的DMSO药物,既没有明显的细胞死亡,也没有明显的细胞周期变化。总之,将姜黄素包埋在基于MO的LCN中可能会在将来提供一种策略,以克服与治疗各种癌症的药物的稳定性和细胞摄取问题相关的障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号